BlackRock Fund Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

BlackRock Fund Advisors’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$14.6M	Buy	1,010,270 +583,679	+137%	+$10.3M	﹤0.01%	2359
2016 Q3	$9.83M	Buy	426,591 +93,926	+28%	+$1.79M	﹤0.01%	2480
2016 Q2	$5.52M	Buy	332,665 +165,483	+99%	+$3.34M	﹤0.01%	2739
2016 Q1	$2.65M	Sell	167,182 -3,939	-2%	-$70K	﹤0.01%	2995
2015 Q4	$5.53M	Buy	171,121 +6,354	+4%	+$275K	﹤0.01%	2787
2015 Q3	$6.95M	Buy	+164,767	New	+$7.77M	﹤0.01%	2589

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors's GBT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Global Blood Therapeutics, Inc. (GBT) stake by 137% in Q4 2016, buying an estimated $10.3M and bringing the position to 1,010,270 shares worth $14.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2359.

BlackRock Fund Advisors first reported a position in GBT in Q3 2015 and has held it in 6 quarters since. 96 funds tracked by Wall St. Rank hold GBT as of Q4 2016.

BlackRock Fund Advisors held 1,010,270 shares of Global Blood Therapeutics, Inc. worth $14.6M as of Q4 2016.
BlackRock Fund Advisors bought 583,679 Global Blood Therapeutics, Inc. shares in Q4 2016, an estimated $10.3M.
Global Blood Therapeutics, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2359 holding.
BlackRock Fund Advisors first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and has held it in 6 quarters since.
96 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.